Your browser doesn't support javascript.
loading
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.
Anker, Stefan D; Schroeder, Stefan; Atar, Dan; Bax, Jeroen J; Ceconi, Claudio; Cowie, Martin R; Crisp, Adam; Dominjon, Fabienne; Ford, Ian; Ghofrani, Hossein-Ardeschir; Gropper, Savion; Hindricks, Gerhard; Hlatky, Mark A; Holcomb, Richard; Honarpour, Narimon; Jukema, J Wouter; Kim, Albert M; Kunz, Michael; Lefkowitz, Martin; Le Floch, Chantal; Landmesser, Ulf; McDonagh, Theresa A; McMurray, John J; Merkely, Bela; Packer, Milton; Prasad, Krishna; Revkin, James; Rosano, Giuseppe M C; Somaratne, Ransi; Stough, Wendy Gattis; Voors, Adriaan A; Ruschitzka, Frank.
Afiliação
  • Anker SD; Innovative Clinical Trials, Depar tment of Cardiology & Pneumology, University Medical Center Göttingen (UMG), Germany.
  • Schroeder S; Bayer Pharma AG, Berlin, Germany.
  • Atar D; Department of Cardiology B, Oslo University Hospital Ulleval and University of Oslo, Norway.
  • Bax JJ; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Ceconi C; Unit of Cardiology, Hospital of Desenzano del Garda, Desenzano del Garda, Italy.
  • Cowie MR; National Heart and Lung Institute, Imperial College London, London, UK.
  • Crisp A; GlaxoSmithKline, Middlesex, UK.
  • Dominjon F; Servier International, Paris, France.
  • Ford I; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
  • Ghofrani HA; University of Giessen and Marburg Lung Center, UGMLC [member of the German Center for Lung Research (DZL)], Giessen, Germany.
  • Gropper S; Kerckhoff-Klinik Bad Nauheim, Germany.
  • Hindricks G; Imperial College London, UK.
  • Hlatky MA; Boehringer-Ingelheim GmBH & Co. KG, Ingelheim, Germany.
  • Holcomb R; Department of Electrophysiology, Heart Center, University of Leipzig, Leipzig, Germany.
  • Honarpour N; Stanford University School of Medicine, Stanford, CA, USA.
  • Jukema JW; Independent Biostatistician, Minneapolis, MN, USA.
  • Kim AM; Amgen, Inc., Thousand Oaks, CA, USA.
  • Kunz M; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Lefkowitz M; Pfizer, Inc., Cambridge, MA, USA.
  • Le Floch C; Bayer Pharma AG, Berlin, Germany.
  • Landmesser U; Novartis Pharmaceuticals, East Hanover, NJ, USA.
  • McDonagh TA; Servier International, Paris, France.
  • McMurray JJ; Department of Cardiology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Merkely B; King's College Hospital, London, UK.
  • Packer M; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Prasad K; Semmelweis University Heart and Vascular Center, Budapest, Hungary.
  • Revkin J; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Rosano GM; United Kingdom Medicines and Healthcare Products Regulatory Agency, London, UK.
  • Somaratne R; Pfizer, Inc., Cambridge, MA, USA.
  • Stough WG; IRCCS San Raffaele Hospital Roma, Rome, Italy.
  • Voors AA; Cardiovascular and Cell Sciences Institute, St. George's University of London, London, UK.
  • Ruschitzka F; Amgen, Inc., Thousand Oaks, CA, USA.
Eur J Heart Fail ; 18(5): 482-9, 2016 05.
Article em En | MEDLINE | ID: mdl-27071916

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Mortalidade / Insuficiência Cardíaca / Hospitalização Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Eur J Heart Fail Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Mortalidade / Insuficiência Cardíaca / Hospitalização Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Eur J Heart Fail Ano de publicação: 2016 Tipo de documento: Article